Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved methodology for analyzing local and distant recurrence.

R Gelman1, R Gelber, I C Henderson

  • 1Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA 02115.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

Public health oncology: a framework for progress in low- and middle-income countries.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Normal tissue protection for improving radiotherapy: Where are the Gaps?

Translational cancer research·2012
Same author

Advances in cellular and molecular radiation oncology.

Urologic oncology·2011
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Actuarial methods for cancer treatment failure overestimate local control by ignoring competing risks. These statistical methods incorrectly assume independence between local and distant failure, leading to flawed interpretations of treatment effectiveness.

Area of Science:

  • Oncology
  • Biostatistics
  • Medical Statistics

Background:

  • Cancer treatment studies often use actuarial methods to estimate local failure rates.
  • These methods, adapted from survival analysis, treat distant failure or death as censored events.
  • However, the interpretation of these analyses is frequently inaccurate.

Purpose of the Study:

  • To highlight the misinterpretation of actuarial methods in cancer treatment analysis.
  • To explain the concepts of statistical independence, nonidentifiability, and competing risks.
  • To illustrate the pitfalls of using actuarial methods for assessing local tumor control.

Main Methods:

  • Review of statistical methods used in cancer treatment research.
  • Explanation of competing risks in the context of cancer failure.

Related Experiment Videos

  • Illustration of how actuarial methods can overestimate local control.

    • Main Results:

    • Actuarial methods incorrectly assume statistical independence between local and distant failure.
    • This assumption is often violated in human malignancies.
    • Failure to account for competing risks leads to overestimation of local control.

    Conclusions:

    • Actuarial methods are inappropriate for analyzing time to local failure when other failure modes exist.
    • Competing risks must be considered for accurate assessment of cancer treatment outcomes.
    • Misapplication of these statistical methods can lead to incorrect conclusions about treatment efficacy.